"To market" is a verrrrryy long path excluding fast track options but even with that it's still a long way out with nothing yet even put into humans. Assuming no fast track and getting into clinic for a Phase 1 trial next year ? 2025/26 ? Fast track option presumably on Phase II data and assuming they get to clinic next year 2023/24 ? …. I still think first in human Phase I would more likely be 2021 but happy to be proven wrong.
"To market" is a verrrrryy long path excluding fast track...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.005(5.00%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.8¢ | 10.3¢ | $421.2K | 4.009M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 872943 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 341133 | 4 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PYC (ASX) Chart |